Skip to content
Screener

Acadia Pharmaceuticals ACAD Book value per share

Book value per share at other companies

Biogen logo
BiogenBIIB
$126.75+5.4%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$32.95+33.2%
MapLight Therapeutics, Inc. logo
MapLight Therapeutics, Inc.MPLT
$8.83+103%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$0.58+183%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$3.55+70.5%
LBR
LB Pharmaceuticals IncLBRX
$13.41+105%

Other financials

Income statement

See full
Revenue$308.0M+16.4%
Gross profit$279.6M+14.7%
Operating income$37.8M+16.9%
Net income$31.5M+18.1%
EPS (diluted)$0.18+12.5%

Balance sheet

See full
Cash & equivalents$385.0M+51.8%
Total debt$73.9M+31.2%
Total equity$1.3B+58.9%
Total assets$1.7B+42.2%

Cash flow

See full
Operating cash flow$100.8M+57.6%
CapEx$5.1M+1,613%
Free cash flow$95.7M+50.3%

Valuation

See full
Market cap$4.9B+23.1%
Enterprise value$4.59B+21.3%
P/E12.9×-5.0×
P/S4.3×+0.4×

Profitability

See full
Gross margin91.1%-0.8pp
Operating margin7.6%-15.7pp
Net margin33.4%+11.6pp
FCF margin18.9%—

Returns & leverage

See full
Return on equity35.7%+2.6pp
Debt / equity0.1×0.0×
Current ratio3.4×+0.5×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

total stockholders equity/weighted shares diluted=$7.56

Based on the most recent quarter.

The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 4, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333243

FAQ

What is Acadia Pharmaceuticals's book value per share?
Acadia Pharmaceuticals (ACAD) reported book value per share of $7.56 in Q2 2026.
How has Acadia Pharmaceuticals's book value per share changed year-over-year?
Acadia Pharmaceuticals's book value per share increased by 55.0% year-over-year, from $4.88 to $7.56.
What is the long-term trend for Acadia Pharmaceuticals's book value per share?
Over 5 years (2020 to 2025), Acadia Pharmaceuticals's book value per share has grown at a 12.6% compound annual growth rate (CAGR), from $3.99 to $7.22.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.

Ask your AI about Acadia Pharmaceuticals's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude